- Home
- XNCR vs GLP Comparison
XNCR vs GLP Comparison
Compare XNCR & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | GLP |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2013 | 2005 |
Fundamental Metrics
Financial Performance| Metric | XNCR | GLP |
|---|---|---|
| Price | $23.51 | $50.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $22.33 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 1.3M | 44.7K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 6.40% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $125,576,000.00 | ★ $18,561,421,000.00 |
| Revenue This Year | N/A | $64.13 |
| Revenue Next Year | $4.80 | $11.74 |
| P/E Ratio | ★ N/A | $23.28 |
| Revenue Growth | ★ 13.65 | 8.14 |
| 52 Week Low | $8.49 | $39.58 |
| 52 Week High | $30.61 | $54.29 |
Technical Indicators
Market Signals| Indicator | XNCR | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 49.15 |
| Support Level | $11.20 | $45.65 |
| Resistance Level | $30.61 | N/A |
| Average True Range (ATR) | 1.45 | 1.08 |
| MACD | -0.70 | -0.01 |
| Stochastic Oscillator | 9.93 | 36.85 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About GLP Global Partners LP
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.